The Development and Study of a 3D-Printed Model for Surgical Planning of Lung Cancer with Realistic Subsegmental Boundaries and Complete Tissue Structures
1 other identifier
observational
150
1 country
1
Brief Summary
This project focuses on the development of a precision multi-organ surgical planning model aided by artificial intelligence (AI), computer-aided design (CAD), multi-material 3D printing, and multimodal 3D modeling. The integration of these advanced technologies aims to enhance the accuracy and efficiency of preoperative planning for complex surgical procedures involving multiple organs. By leveraging AI and CAD, the project seeks to create detailed, patient-specific 3D models that incorporate various imaging modalities. These models will be used to guide multi-material 3D printing, producing highly accurate replicas of anatomical structures. The ultimate goal is to improve surgical outcomes by providing surgeons with precise and comprehensive tools for planning and executing intricate surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 12, 2024
CompletedFirst Posted
Study publicly available on registry
July 18, 2024
CompletedSeptember 19, 2024
September 1, 2024
11 months
July 12, 2024
September 17, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Operation Time
Measure the total duration of the surgery in minutes.
During the surgery
Blood Loss
Assess the total blood loss during surgery in milliliters.
During the surgery
Postoperative Complications
Record any complications within 30 days post-surgery.
Within 30 days post-surgery
Study Arms (2)
3D reconstruction
Patients in this group underwent surgical planning with the aid of 3D reconstruction technology, which included preoperative imaging and 3D modeling to assist in the planning of thoracic surgery.
Non-3D reconstruction
Patients in this group underwent traditional surgical planning without the use of 3D reconstruction technology, relying on standard preoperative imaging and planning techniques.
Interventions
Utilization of 3D reconstruction technology to assist in preoperative planning and surgical procedures for thoracic surgery patients.
This group did not use 3D reconstruction for surgical navigation
Eligibility Criteria
The study includes all lung cancer patients who underwent surgery at the Affiliated Hospital of Hebei University from 2020 to 2023.
You may qualify if:
- Patients diagnosed with lung cancer
- Complete clinical case data;
- All patients underwent surgical treatment;
- Voluntarily participate in the study and sign the informed consent.
You may not qualify if:
- Severe comorbidities, such as uncontrolled heart disease or diabetes
- History of major surgeries or other interventions
- Unwillingness to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ke Zhanglead
Study Sites (1)
Affiliated Hospital of Hebei University
Baoding, Hebei, 071000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
July 12, 2024
First Posted
July 18, 2024
Study Start
January 1, 2023
Primary Completion
December 1, 2023
Study Completion
January 1, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share